GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Price-to-Owner-Earnings

PharmaCielo (TSXV:PCLO) Price-to-Owner-Earnings : (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Price-to-Owner-Earnings?

As of today (2024-06-10), PharmaCielo's share price is C$0.155. PharmaCielo does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for PharmaCielo's Price-to-Owner-Earnings or its related term are showing as below:


TSXV:PCLO's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.31
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-10), PharmaCielo's share price is C$0.155. PharmaCielo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.08. Therefore, PharmaCielo's PE Ratio for today is At Loss.

As of today (2024-06-10), PharmaCielo's share price is C$0.155. PharmaCielo's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.07. Therefore, PharmaCielo's PE Ratio without NRI for today is At Loss.


PharmaCielo Price-to-Owner-Earnings Historical Data

The historical data trend for PharmaCielo's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Price-to-Owner-Earnings Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

PharmaCielo Quarterly Data
Nov18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaCielo's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaCielo's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaCielo's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaCielo's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PharmaCielo's Price-to-Owner-Earnings falls into.



PharmaCielo Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PharmaCielo's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.155/-0.09
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaCielo  (TSXV:PCLO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PharmaCielo Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCielo (TSXV:PCLO) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.
Executives
Ian D Atacan Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines